We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$22.4B
AUM Growth
+$745M
Cap. Flow
+$687M
Cap. Flow %
3.07%
Top 10 Hldgs %
31.51%
Holding
1,352
New
72
Increased
666
Reduced
342
Closed
71

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$191M
2
MSFT icon
Microsoft
MSFT
+$116M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
AAPL icon
Apple
AAPL
+$108M
5
WY icon
Weyerhaeuser
WY
+$83.8M

Sector Composition

Rank Sector Weight
1 Real Estate 37.54%
2 Technology 23.33%
3 Communication Services 8.01%
4 Consumer Discretionary 6.37%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLRN
1251
DELISTED
ACELYRIN
SLRN
$1K ﹤0.01%
398
TERN
1252
DELISTED
Terns Pharmaceuticals
TERN
$1K ﹤0.01%
151
TNGX icon
1253
Tango Therapeutics
TNGX
$4.22B
$1K ﹤0.01%
355
TSHA icon
1254
Taysha Gene Therapies
TSHA
$1.63B
$1K ﹤0.01%
691
VNDA icon
1255
Vanda Pharmaceuticals
VNDA
$298M
$1K ﹤0.01%
191
VWO icon
1256
Vanguard FTSE Emerging Markets ETF
VWO
$118B
$1K ﹤0.01%
30
-25
-45% -$1.16K
VYGR icon
1257
Voyager Therapeutics
VYGR
$187M
$1K ﹤0.01%
201
XERS icon
1258
Xeris Biopharma Holdings
XERS
$1.45B
$1K ﹤0.01%
404
YMAB
1259
DELISTED
Y-mAbs Therapeutics
YMAB
$1K ﹤0.01%
162
ALMS
1260
Alumis Inc
ALMS
$3.36B
$1K ﹤0.01%
+156
New +$1.56K
RVNC
1261
DELISTED
Revance Therapeutics, Inc.
RVNC
$1K ﹤0.01%
331
ACRS icon
1262
Aclaris Therapeutics
ACRS
$714M
-248
Closed
ALXO icon
1263
ALX Oncology
ALXO
$262M
-138
Closed
AMRC icon
1264
Ameresco
AMRC
$991M
-90,700
Closed -$3.44M
ATAI icon
1265
AtaiBeckley Inc
ATAI
$2.66B
-468
Closed -$1K
BBWI icon
1266
Bath & Body Works
BBWI
$3.99B
-26,872
Closed -$858K
BLUE
1267
DELISTED
bluebird bio
BLUE
$0 ﹤0.01%
16
-1
-6% -$9
BMEA icon
1268
Biomea Fusion
BMEA
$90.4M
$0 ﹤0.01%
109
BMO icon
1269
Bank of Montreal
BMO
$124B
-120
Closed -$11K
BNS icon
1270
Scotiabank
BNS
$106B
-50
Closed -$3K
CABA icon
1271
Cabaletta Bio
CABA
$432M
-175
Closed -$1K
CCS icon
1272
Century Communities
CCS
$1.99B
-1,400
Closed -$144K
CHRD icon
1273
Chord Energy
CHRD
$7.63B
-4,600
Closed -$599K
CHRS icon
1274
Coherus Oncology
CHRS
$219M
-262
Closed
CRBU icon
1275
Caribou Biosciences
CRBU
$146M
-176
Closed

Similar funds

Daiwa Securities Group's Q4 2024 Portfolio in Review

As of Q4 2024, Daiwa Securities Group held 1,352 positions worth $22.4B, up 3.4% from $21.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group deployed $687M of net new capital in Q4 2024, opening 72 new positions and adding to 666 existing holdings. Its largest new stake was Curbline Properties: 2,033,334 shares worth $47.2M.

By sector, the portfolio is most concentrated in Real Estate at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $118M trimmed.

  • Daiwa Securities Group's largest Q4 2024 buy was Curbline Properties: 2,033,334 shares worth $47.2M.
  • Daiwa Securities Group added most to American Tower in Q4 2024, an estimated $191M increase.
  • Daiwa Securities Group's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $118M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $22.4B portfolio in Q4 2024.
  • Daiwa Securities Group opened 72 new positions and closed 71 in Q4 2024.
  • Daiwa Securities Group's portfolio value rose 3.4% quarter-over-quarter to $22.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.